Plasma Citrulline Level in Relation to Absorptive Surface

July 7, 2021 updated by: University Hospital, Ghent

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies

Study Overview

Status

Completed

Conditions

Intestinal Failure

Intervention / Treatment

Procedure: Blood sampling

Study Type

Interventional

Enrollment (Actual)

200

Phase

Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Belgium
- - Ghent, Belgium, 9000
    - University Hospital Ghent

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Description

Inclusion Criteria:

0-18 years
preterm babies up to 1.500g
preterm babies over 1.500g

Exclusion Criteria:

gastro-intestinal problems (except for the preterm babies)
congenital metabolic disorders
dysfunction of the liver or kidneys
congenital defects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Diagnostic
Allocation: Non-Randomized
Interventional Model: Single Group Assignment
Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Correlation between determination of citrulline in plasma or dried blood Time Frame: Untill end of study	Untill end of study
Reference ranges for healthy children and babies Time Frame: Until end of study	Until end of study
Longitudinal follow-up of citrulline in preterm babies Time Frame: Untill end of study	Untill end of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Ghent

Investigators

Principal Investigator: Eddy Robberecht, MD, PhD, University Hospital, Ghent

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

website University Hospital Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2005

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

September 1, 2010

Study Registration Dates

First Submitted

February 1, 2006

First Submitted That Met QC Criteria